Pandora, Gap Post R...
Health Care: Drugs
Catalyst Pharmaceutical Partners Inc. (CPRX: NASDAQ)
$0.84 -0.01 | -1.72%
05/23/13 - 03:59 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.85 |
| 52 Week High | 2.27 |
| 52 Week Low | 0.37 |
| Avg. Daily Vol. (Mil) | 0.76 |
| Beta (3 year) | 0.67 |
| Share Related Items | |
| Mkt Cap (Mil) | 35.19 |
| Shares Out (Mil) | 41.42 |
| Float (Mil) | 29.11 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 13.00 |
| Current Ratio | 14.60 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 2.72 |
| Price/Cash Flow | -5.80 |
| Per Share Data | |
| Earnings | -0.13 |
| Sales | 0.00 |
| Book Value | 0.31 |
| Cash Flow | -0.15 |
| Business Summary | |
|---|---|
| Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical Company, focused on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. | |
| General Information | |
| 355 Alhambra Circle
Suite 1370 Coral Gables, FL 33134 |
|
| www.catalystpharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 6 | |
| CEO: Patrick J. McEnany | |
| Short Interest | |
| Current Month (Mil) | 3.50 |
| Previous Month (Mil) | 2.41 |
| Short Interest Ratio (Days) | 2.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -42.20 |
| Return on Investments | -47.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with CPRX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- UserWatch
- ContributorStocks Under-$10 Setting Up...
- UserStan/Gino
- ContributorStocks Under-$10 Moving Hig...
- UserBiotech88
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
Latest CPRX Headlines from TheStreet
- Catalyst Pharmaceutical Partners Reports First Quarter 2013 Financial Results 05.16.13 | 08:05 am
- Catalyst Pharmaceutical Partners Reports Fourth Quarter And Year-End 2012 Financial Results 04.02.13 | 08:04 am
- Catalyst Pharmaceutical Partners Announces Recommendation Of Data Monitoring Committee For Pivotal Phase Lll Clinical Trial For Firdapse(TM) 03.27.13 | 08:03 am
- Catalyst Pharmaceutical Partners To Present At 25th Annual ROTH Conference 03.07.13 | 08:03 am
- Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera As Vice President Of Clinical Operations 03.05.13 | 08:03 am
- Catalyst Pharmaceutical Partners Launches New Website 02.21.13 | 08:02 am
- Catalyst Pharmaceutical Partners Provides Update On Research And Development Pipeline 02.11.13 | 08:02 am
- 3 Biotech Stocks Under $5 Moving Higher 02.07.13 | 02:02 pm
- Catalyst Pharmaceutical Partners To Present At 15th Annual BIO CEO & Investor Conference 02.05.13 | 08:02 am
- Catalyst Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement 12.27.12 | 08:12 am
Press Releases for CPRX
- The Market Slips Lower And EBay Falls On Earnings Outlook - PR Newswire 04.19.13 | 07:04 am
- Vigabatrin/CPP-109 Data To Be Presented At College On Problems Of Drug Dependence Annual Meeting - PR Newswire 06.09.10 | 08:06 am
- Catalyst Pharmaceutical Partners To Present At The MoneyShow Conference - PR Newswire 05.07.10 | 08:05 am
- Catalyst Pharmaceutical Partners Regains Compliance With NASDAQ Minimum Bid Price Rule - PR Newswire 04.26.10 | 11:04 am
- Catalyst Pharmaceutical Partners Signs Definitive Agreement With The National Institute On Drug Abuse To Conduct U.S. Phase II(B) Clinical Trial For Cocaine Addiction - PR Newswire 04.13.10 | 10:04 am
- CPP-109 Clinical Trial Data To Be Presented At The American Society Of Addiction Medicine Annual Medical-Scientific Conference - PR Newswire 04.09.10 | 08:04 am
- Catalyst Pharmaceutical Partners Reports Fourth Quarter And Year-End 2009 Financial Results - PR Newswire 04.01.10 | 08:04 am
- Catalyst Pharmaceutical Partners To Present At The BioNetwork East 2010 Conference - PR Newswire 03.10.10 | 08:03 am
- Catalyst Pharmaceutical Partners To Present Today At 2010 Epilepsy Pipeline Update Conference - PR Newswire 02.25.10 | 08:02 am
- Catalyst Pharmaceutical Partners And The National Institute On Drug Abuse Plan To Initiate U.S. Phase II(b) Clinical Trial For Cocaine Addiction - PR Newswire 02.23.10 | 08:02 am
Partner Headlines for CPRX
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 11.07.12 | 09:11 am
- Morning Market Losers - Benzinga 09.26.12 | 09:09 am
- Under Construction Rehash: Buy Acadia And Astex - Seeking Alpha 09.20.12 | 09:09 am
- Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD - GuruFocus 07.09.12 | 01:07 pm
- Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN - GuruFocus 06.04.12 | 01:06 pm
- 7 Stocks Under $6 Poised To Double In 2012 - Seeking Alpha 11.24.11 | 06:11 am
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 10.14.11 | 09:10 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 10.10.11 | 09:10 am
- Morning Market Losers - Benzinga 06.06.11 | 09:06 am
